
Axis India Manufacturing Fund(G)-Direct Plan
+15.23%
1Y annualised
+15.23%
1Y annualised
+0.12% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.

NAV : 13 Nov 2026
₹17.02
Min. SIP amount
₹500
Fund size (AUM)
5353 Cr
Expense ratio
0.52%
Launched on
21 Dec 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 13 Nov 2026
₹17.02
Min. SIP amount
₹500
Fund size (AUM)
5353 Cr
Expense ratio
0.52%
Launched on
21 Dec 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
45.69%
Mid Cap
17.02%
Small Cap
26.66%
Others
10.63%
Sector Allocation
Automobile & Ancillaries
30.62%
Capital Goods
16.22%
Healthcare
14.97%
Domestic Equities
8.41%
Cash & Cash Equivalents And Net Assets
6.58%
Crude Oil
3.85%
Consumer Durables
3.81%
Chemicals
3.48%
Others
11.60%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
NIL for 10% of investment and 1% for remaining investment on or before 90D, Nil after 90D
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Nitin Arora
Present
Pratik Tibrewal
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
Mirae Asset Healthcare Fund(G)-Direct Plan
Edelweiss Recently Listed IPO Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
WOC Pharma and Healthcare Fund(G)-Direct Plan
PGIM India Healthcare Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.
